Study guide
4.3 Antifungals, Antivirals & Antituberculars
DHA Pharmacist Licensing Assessment PHO5481
Track your progress as you read
Finished sections get a check mark.
1 Exam Overview & Licensing Pathway
1.1 Current Exam Facts & Format 1.2 Eligibility, PQR & the Sheryan Application Process 1.3 Study Strategy & Test-Day Plan
2 Cardiovascular Pharmacology
2.1 Antihypertensives & RAAS Agents 2.2 Heart Failure & Antiarrhythmic Drugs 2.3 Lipid-Lowering & Antianginal Agents
3 Endocrine & Metabolic Pharmacology
3.1 Insulin & Oral Antidiabetic Agents 3.2 Thyroid, Bone & Calcium Agents 3.3 Corticosteroids & Other Hormonal Agents
4 Anti-Infective Pharmacology
4.1 Beta-Lactam Antibiotics 4.2 Non-Beta-Lactam Antibacterials 4.3 Antifungals, Antivirals & Antituberculars
5 CNS, Psychiatric & Pain Pharmacology
5.1 Psychiatric Pharmacology 5.2 Antiepileptics & Neurologic Agents 5.3 Analgesics: NSAIDs, Opioids & Migraine
6 Respiratory, GI & Hematology Pharmacology
6.1 Respiratory Pharmacology 6.2 Gastrointestinal Pharmacology 6.3 Anticoagulants, Antiplatelets & Hematology Agents
7 Pharmaceutical Care: Cardiometabolic Disease
7.1 Diabetes Management & Counseling 7.2 Hypertension & Dyslipidemia Management 7.3 Heart Failure & Anticoagulation Management
8 Pharmaceutical Care: Respiratory, Rheumatology & Infection
8.1 Asthma & COPD Management 8.2 Gout, Pain & Rheumatologic Care 8.3 Infection Management & Antimicrobial Stewardship
9 Counseling, Monitoring & Special Populations
9.1 Patient Counseling, Adherence & Health Literacy 9.2 Therapeutic Monitoring & Laboratory Interpretation 9.3 Pregnancy, Pediatrics, Geriatrics & Organ Impairment 9.4 Pharmacoeconomics & Formulary Decision Making
10 Pharmaceutical Calculations I
10.1 Concentration, Ratio & Percentage Strength 10.2 Weight-Based & BSA Dosing 10.3 Dilution, Concentration & Alligation
11 Pharmaceutical Calculations II
11.1 Infusion Rates & IV Flow Calculations 11.2 Dispensing Quantities & Days' Supply 11.3 Compounding Calculations, Isotonicity & Milliequivalents
12 UAE Pharmacy Law & Regulation
12.1 UAE Regulatory Framework & Licensing Authorities 12.2 Medicine Registration, Pricing & Supply Chain 12.3 Prescription Requirements & Validity
13 Controlled Drugs, Ethics & Pharmacovigilance
13.1 Controlled & Semi-Controlled Medicines in the UAE 13.2 Ethics, Confidentiality & Generic Substitution 13.3 Pharmacovigilance, Recall & Medicine Disposal
14 Pharmacokinetics I: ADME
14.1 Absorption & Bioavailability 14.2 Distribution & Protein Binding 14.3 Metabolism & Elimination
15 Pharmacokinetics II: Kinetics, Dosing & TDM
15.1 Half-Life, Clearance & Kinetic Order 15.2 Loading & Maintenance Dosing 15.3 Therapeutic Drug Monitoring
16 OTC Medicines & Self-Care
16.1 Cough, Cold & Allergic Rhinitis 16.2 GI Self-Care: Heartburn, Constipation & Diarrhoea 16.3 Pain & Fever Self-Care 16.4 Referral Red Flags, Emergency Contraception & Skin
17 Medication Safety
17.1 High-Alert Medications & Error-Prone Abbreviations 17.2 Medication Reconciliation & Duplicate Therapy 17.3 Adverse Drug Reactions & Hypersensitivity Recognition
18 Sterile & Nonsterile Compounding
18.1 Aseptic Technique & Compounding Environments 18.2 Parenteral, TPN & Cytotoxic Preparation 18.3 Nonsterile Compounding
19 Pharmaceutics, Biopharmaceutics & Toxicology
19.1 Dosage Form Design & the Biopharmaceutics Classification System 19.2 Dissolution & Excipients 19.3 Toxicology: Poisoning Recognition & Antidotes
20 Infection Control, Natural Products, Medicinal Chemistry & Pharmacogenomics
20.1 Infection Control & Immunization 20.2 Pharmacognosy & Dietary Supplements 20.3 Medicinal Chemistry Essentials 20.4 Clinical Pharmacogenomics
4.3 Antifungals, Antivirals & Antituberculars
Key Takeaways Explain This Topic AI
Azoles inhibit 14-alpha-demethylase and ergosterol synthesis; fluconazole inhibits CYP2C9/3A4 and prolongs QT, while voriconazole causes transient visual disturbances and phototoxicity
Amphotericin B's dose-limiting toxicity is nephrotoxicity with infusion reactions (fever and rigors); liposomal formulations reduce both
Acyclovir can crystallize in renal tubules — ensure hydration and renally adjust; oseltamivir works best when started within 48 hours of influenza symptom onset
Abacavir requires HLA-B*57:01 screening before use to prevent a potentially fatal hypersensitivity reaction
RIPE therapy: rifampicin (orange body fluids, potent CYP inducer causing OCP failure), isoniazid (B6-deficiency neuropathy, hepatotoxicity), pyrazinamide (hyperuricemia), ethambutol (optic neuritis with red-green color blindness); standard regimen is 2HRZE/4HR
Last updated: August 2026
Antifungals
Azole antifungals inhibit fungal 14-alpha-demethylase , blocking conversion of lanosterol to ergosterol and destabilizing the fungal membrane. The class differs in spectrum and toxicity:
Fluconazole — Candida (though C. krusei is intrinsically resistant and C. glabrata often dose-dependently resistant) and cryptococcal meningitis. Excellent oral bioavailability and CSF penetration. It inhibits CYP2C9 and CYP3A4 (raising warfarin, phenytoin, and sulfonylurea levels), prolongs the QT interval , and can cause hepatotoxicity. Single-dose use for vaginal candidiasis is common, but prolonged high-dose exposure is avoided in pregnancy.
Itraconazole — broader, including dimorphic fungi and onychomycosis. It is a negative inotrope and is contraindicated in heart failure; capsule absorption requires gastric acid (avoid proton pump inhibitors, take with food or cola), whereas the solution is taken on an empty stomach.
Voriconazole — first-line for invasive aspergillosis . Signature adverse effects are transient visual disturbances (blurred vision, photophobia, altered color perception in up to a third of patients), phototoxicity with long-term skin cancer risk, hallucinations, and hepatitis. It is metabolized by CYP2C19 , whose genetic polymorphism makes levels unpredictable — therapeutic drug monitoring is recommended. Like all azoles it is a strong CYP inhibitor with many interactions.
Amphotericin B binds ergosterol directly, forming membrane pores; it has the broadest antifungal spectrum and is reserved for severe systemic mycoses. Its conventional formulation is notorious for dose-limiting nephrotoxicity , infusion reactions (fever, rigors — "shake and bake" — managed with premedication and slow infusion), and electrolyte wasting ( hypokalemia and hypomagnesemia ). Liposomal amphotericin B substantially reduces nephrotoxicity and infusion reactions and is preferred when renal function or cost allows. Pre-hydration with normal saline further protects the kidney.
Echinocandins — caspofungin , micafungin, anidulafungin — inhibit 1,3-beta-D-glucan synthase , a target absent from human cells, making them exceptionally well tolerated. They are fungicidal against Candida and first-line for candidemia, but are intravenous-only and unreliable against Cryptococcus.
Terbinafine inhibits squalene epoxidase and is first-line oral therapy for onychomycosis (6 weeks fingernails, 12 weeks toenails). Counsel on hepatotoxicity — baseline and interval liver function tests — and taste disturbance (dysgeusia) , which can persist for months. Topical agents round out the class: clotrimazole and miconazole creams for dermatophyte and candidal skin infections, oral terbinafine cream for tinea, and nystatin , which is not absorbed and is used topically or as an oral suspension for thrush.
Antivirals
Acyclovir and its oral prodrug valacyclovir are guanosine analogues activated by viral thymidine kinase (conferring selective toxicity), then incorporated into viral DNA as chain terminators . They treat HSV and VZV infections; higher doses are needed for herpes zoster and encephalitis. The key toxicity is renal crystalluria with obstructive nephropathy — preventable with adequate hydration and renal dose adjustment — and neurotoxicity (confusion, tremor) in renal impairment. Oseltamivir , a neuraminidase inhibitor , shortens influenza illness and is most effective when started within 48 hours of symptom onset ; it is also used for post-exposure prophylaxis. Nausea and vomiting are the main adverse effects, and dosing is renally adjusted.
For HIV , combination antiretroviral therapy uses drugs from several classes: NRTIs (tenofovir, emtricitabine, lamivudine — and abacavir , which mandates HLA-B*57:01 screening because carriers risk a severe, potentially fatal hypersensitivity reaction), NNRTIs (efavirenz, notable for CNS effects and CYP interactions), integrase strand transfer inhibitors (dolutegravir, bictegravir — now preferred first-line anchors because of high barrier to resistance and tolerability), and boosted protease inhibitors. For hepatitis C , direct-acting antivirals such as sofosbuvir (NS5B polymerase inhibitor) combined with velpatasvir (NS5A inhibitor) are pangenotypic , oral, and cure over 95% of patients in 8–12 weeks; key checks before starting are drug-drug interactions (many are P-glycoprotein substrates affected by inducers like rifampicin) and hepatitis B screening because of reactivation risk.
Tuberculosis: RIPE Therapy
Active tuberculosis is treated with a standard short-course regimen: 2 months of HRZE (rifampicin, isoniazid, pyrazinamide, ethambutol) followed by 4 months of HR (rifampicin plus isoniazid) — written 2HRZE/4HR . Using four drugs initially prevents emergence of resistance while susceptibility results are awaited, and adherence is supported through directly observed therapy (DOTS) -style programs because defaulting breeds multidrug-resistant TB. Each first-line agent has a mechanism and a trademark toxicity:
Drug Mechanism Key adverse effects and counseling
Rifampicin Inhibits DNA-dependent RNA polymerase Orange discoloration of tears, urine, sweat (soft contact lenses may stain); potent CYP3A4/P-gp inducer — causes oral contraceptive failure , reduces warfarin and many antiretroviral levels; hepatotoxicity; take on an empty stomach
Isoniazid Inhibits mycolic acid (cell-wall) synthesis Peripheral neuropathy from pyridoxine (vitamin B6) deficiency — co-prescribe B6 in at-risk patients (pregnancy, diabetes, malnutrition, HIV, renal failure); hepatotoxicity (risk rises with age and alcohol); inhibits CYP enzymes, raising phenytoin levels
Pyrazinamide Disrupts membrane energetics in acidic environments Hyperuricemia and gout (avoid or monitor in gout); the most hepatotoxic of the four; not used in pregnancy in some guidelines
Ethambutol Inhibits arabinosyl transferase (cell-wall arabinogalactan) Dose-related optic neuritis with red-green color blindness and reduced visual acuity — check baseline and monthly vision; renally cleared; generally avoided in young children who cannot report visual changes
Monitoring fundamentals for the regimen: baseline liver function, renal function, and visual testing; monthly clinical review for hepatitis symptoms (anorexia, dark urine, jaundice) — asymptomatic transaminase rises under three times the upper limit of normal are usually tolerated, but symptomatic hepatitis mandates stopping the hepatotoxic drugs. Women of childbearing age on rifampicin must be offered non-hormonal or higher-dose contraception because enzyme induction causes pill failure. Pyridoxine 10 mg daily accompanies isoniazid in neuropathy-prone patients. Finally, rifampicin's induction persists for about two weeks after stopping, so interaction management outlives the last dose — a detail that distinguishes strong candidates on CBT exams.